Sentences with phrase «biological therapies for»

A veterinary oncologist is an expert in the biology of cancer and specializes in the use of chemotherapy and biological therapies for the treatment of cancer.

This is a summary sheet including all information needed for AQA new specification psychology «biological therapies for schizophrenia».

«Our study reveals a new mechanism that could be harnessed for biological therapies for lupus and other autoimmune diseases, where the immune system mistakenly targets the body's own cells,» says senior study author Boris Reizis, PhD, professor of Pathology and Medicine at NYU Langone.

«In particular, his approach can be thought of as a very advanced biological therapy for the treatment of breast cancer; one that uses viruses, which are better recognized to cause disease, to treat human breast cancers.»

Topic: Schizophrenia 0 1 Outline and evaluate one biological therapy for schizophrenia and one psychological therapy for schizophrenia.

Not exact matches

And a third, different kind of gene therapy from Spark Therapeutics — to treat a rare inherited form of blindness — is likely to be approved by the end of 2017, too, making this year a landmark for treatments that manipulate the body's own biological mechanisms in novel new ways to fight deadly diseases.

Using advances in genomic sequencing, the human microbiome, proteomics, informatics, computing, and cell therapy technologies, HLI is building the world's most comprehensive database of human genotypes and phenotypes as a basis for a variety of commercialization opportunities to help solve aging related disease and human biological decline.

Mining that data is critical to developing therapies that target key points in relevant biological pathways — and represents opportunities for bioinformatics experts, Chung says.

After decades of hopes raised and dashed, pediatricians, immunologists, and others are cautiously hopeful that new biological insights and a push for treatment from parents - to - be could turn the tide for prenatal stem cell therapy.

This matters for the optimisation of ion - beam cancer therapy, which requires a thorough understanding of the relation between the physical characteristics of the incoming ion beam and its effects on biological tissues.

«We are joining everyone who spends their days thinking about preventing cancer, about better understanding its biological basis, about bringing early detection and education to all communities, about developing new treatments and therapies and about caring for patients and their families through some of the hardest days anyone faces.»

«Alcohol prevents ability to extinguish fearful memories in mice: Insight into cellular mechanisms illuminates biological target for PTSD therapy.»

The journal's home page explains that translational medicine «builds on basic research advances — studies of biological processes using cell cultures, for example, or animal models — and uses them to develop new therapies or medical procedures.»

«In the future, our models should provide robust tools to screen for therapies that impact tumor dormancy and metastasis, and should also provide a platform to solve other biological mysteries that underlie dormancy.»

In future, Bandyopadhyay says, better understanding how chemotherapy agents impact specific biological pathways should allow drug trials to focus on patients who are more likely to respond to the drugs being tested and enable clinicians to identify targeted or combination therapies for patients with a genetic predisposition to resistance.

The Salk team is excited about the possibilities their tool opens up for exploring new biological questions about RNA and protein function, as well as therapies to tackle RNA and protein - based diseases.

At a meeting last week of the International Society for Biological Therapy of Cancer in San Diego, California, Oncolytics Biotech of Calgary in Alberta, Canada, reported positive results from two trials of its drug Reolysin, which contains reovirus.

«This camera has the potential to greatly enhance our understanding of very fast biological interactions and chemical processes that will allow us to build better models of complex, dynamical systems such as cellular respiration, or to help doctors better deliver and monitor light - based therapies,» says Richard Conroy, Ph.D., program director for Optical Imaging at NIBIB.

Professor Sterk commented: «We are living in an era where we have new biological knowledge and new targets for therapy but we largely continue to guide patient management with diagnostic labels.

For people, substitution therapies, which include slow acting opioids (methadone), opioids that produce a partial biological response (buprenorphine) or antagonists that block the opioid receptor (naloxone), are the only available treatments for opioid addiction are often leading to high rates of relapFor people, substitution therapies, which include slow acting opioids (methadone), opioids that produce a partial biological response (buprenorphine) or antagonists that block the opioid receptor (naloxone), are the only available treatments for opioid addiction are often leading to high rates of relapfor opioid addiction are often leading to high rates of relapse.

Their findings could help to improve breast cancer prevention by targeting these specific biological mechanisms with cancer therapies in at risk patients and potentially lead the way for a new strategy for the use of preventative treatments.

The next step will be to optimize the approach and to extend it to protein - protein interactions, protein - gene interactions, disease - protein interactions, disease - drug interactions all with a view to improving diagnostics and tailoring therapy for the individual patient based on the outcomes of their personal biological network analysis.

Now, in a new study published in the journal Cell, scientists at the Salk Institute for Biological Studies have discovered that a synthetic form of vitamin D, calcipotriol (a drug already approved by the FDA for the treatment of psoriasis), deactivates the switch governing the fibrotic response in mouse liver cells, suggesting a potential new therapy for fibrotic diseases in humans.

In their «Editorial comment to the «NIA - AA Research Framework: Towards a Biological Definition of Alzheimer's Disease,»» Nina Silverberg, Ph.D., Cerise Elliott, Ph.D., Laurie Ryan, Ph.D., Eliezer Masliah, M.D., and Richard Hodes, M.D., of NIA point out that the Framework — in addition to improving early detection and the development of new therapies — could potentially «allow more precise estimates of how many people are at risk [for or living with] Alzheimer's disease, how best to monitor response to therapies, and how to distinguish the effects of Alzheimer's disease from other similar pathologies.»

«I don't think you need to use gene therapy to develop a biological weapon,» Varmus said, pointing out that existing organisms — anthrax and smallpox, for example — are already potent weapons.

An improved understanding of the biological background of musical aptitude can contribute new insights into, for instance, genes that affect normal brain functions, the interactions between genes and the environment and the significance of music as a form of therapy.

We will next consider the methods available to analyze biological networks, demonstrate the application of these principles to selected problems in biology and medicine, and discuss the implications of biological network theory as a construct for characterizing human disease and defining novel therapies.

Where research uncovers possible mechanisms for disease, those working in drug discovery can use these data to develop novel diagnostic or monitoring tools, to develop therapies that address the biological pathways concerned, or to develop companion diagnostics to ensure that new — or existing — therapies are targeted at the correct subgroup of patients.

Dr. Theodore Friedman, then a visiting scientist at the Salk Institute for Biological Sciences in La Jolla, and colleagues posit that gene therapy could be used to replace defective DNA in individuals with genetic conditions.

As a result, they are of great interest for fields such as biological imaging, medical diagnostics, drug delivery, and gene therapy.

BAR HARBOR, MAINE — Recent research by Sandra Rieger, Ph.D., of the MDI Biological Laboratory identifying the underlying mechanisms of peripheral neuropathy, or nerve damage, has raised the prospect that drug therapies can be developed for the treatment of this condition, which causes pain, numbness and / or tingling in the hands and feet.

Using advances in genomic sequencing, the human microbiome, proteomics, informatics, computing, and cell therapy technologies, HLI is building the world's most comprehensive database of human genotypes and phenotypes as a basis for a variety of commercialization opportunities to help solve aging related disease and human biological decline.

LA JOLLA — Scientists at the Salk Institute for Biological Studies have identified a key genetic switch linked to the development, progression and outcome of cancer, a finding that may lead to new targets for cancer therapies.

The ultimate goal is to increase the number of new diagnostics and therapies for patients while reducing the time and cost of developing them, by jointly identifying and validating promising biological targets for several diseases, including type 2 diabetes.

For autologous therapies, each patient represents an individual production batch and introduces his or her own unique biological differences to a process.

In March 2006, the Burnham Biomedical Research Institute (subsequently renamed the Sanford Burnham Prebys Medical Discovery Institute), the Salk Institute for Biological Studies, The Scripps Research Institute and the UC San Diego formed San Diego Consortium for Regenerative Medicine and adopted the mission of expanding collaborative stem cell research and translating discoveries into clinical therapies and cures.

LA JOLLA, CA — Using a gene therapy delivery system developed in the laboratory of Inder Verma at the Salk Institute for Biological Studies, an international team of researchers successfully treated two...

By emulating biological principles of self assembly, organization and regulation, we are developing disruptive technology solutions for healthcare, energy, architecture, robotics, and manufacturing, which are translated into commercial products and therapies through formation of new startups and corporate alliances.

Simona thinks that this cell biological approach could help make sense of the heterogeneity of gliomas and improve our understanding of invasion overall: «These are key questions — we need to know how invasion is driven as it could have profound implications for therapy».

Biological and clinical follow - up studies on known and new genes will improve understanding of the causes of RA, and allow for better risk assessment in Arabs and opportunities to develop new RA therapies.»

San Diego, California, October 6, 2014 — ViaCyte, Inc., a privately - held regenerative medicine company developing a stem cell - derived islet replacement therapy for the treatment of diabetes, called VC - 01 ™, will give two presentations at the annual Stem Cell Meeting on the Mesa Conference, being held at the Estancia La Jolla Hotel & Spa and The Salk Institute for Biological Studies, as follows:

From our roots under the scientific leadership of renowned neurologist Dr. Henry Barnett - whose work with Aspirin as a preventive therapy for heart attack and stroke remains one of the most important developments in 20th century medicine - the Institute has applied that formula to become a national leader in biological, clinical and imaging research.

Novel drug therapies and novel indications of drug therapy, e.g. tyrosine kinase inhibitors in lung disease other than lung cancer, biological treatments for asthma, COPD, cystic fibrosis and interstitial lung disease.

Expertise: Interactions of Ionizing and Non-ionizing Radiation with Biological Tissues, Novel Laser - Based Therapeutics for Brain Tumors, Nanoparticle - Based Photothermal Therapy

We chose to highlight a diverse set of biological processes and experimental systems to make the point that the principles of cross species analysis of basic gene function extend to the study of all human disorders, and can lead to mechanistic understanding of disease pathogenesis and rationale for the development of new therapies.

BAR HARBOR, MAINE — Novo Biosciences Inc., a spinoff of the MDI Biological Laboratory in Bar Harbor, Maine, has announced that it has received a two - year, $ 1.5 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) for the development of MSI - 1436 as a potential regenerative medicine therapy for the treatment of patients who have suffered an acute heart attack.

Conventional medicine's main types of treatment for lymphoma include: • Surgery • Radiation therapy • Chemotherapy • Palliative therapy • Biological therapy • Stem cell transplants • High - dose bone marrow treatment • Steroids

This product comes with addition DIM (Diindolylmethane), which has many healthy biological properties and is now being tested by the National Cancer Institute as a therapy for number of forms of cancer.

The findings, which were published online Sept. 3 in the Journal of Biological Chemistry, could lead to new therapies for age - related muscle weakness and atrophy.

Menopausal hormone therapy is a treatment that is used for women to help relieve annoying symptoms of menopause and to prevent other biological changes, like bone loss due to the reduction * of estrogen and progesterone.